PROGRESSIVE OSTEOPOROSIS DURING ANDROGEN DEPRIVATION THERAPY FOR PROSTATE CANCER

This publication has 28 references indexed in Scilit:

• The effect of combined androgen blockade on bone turnover and bone mineral densities in men treated for prostate carcinoma
  Cancer, 1998
• The clinical significance of antenatal detection of discordant umbilical arteries
  Published by Wolters Kluwer Health ,1998
• Osteoporosis After Orchiectomy for Prostate Cancer
  Journal of Urology, 1997
• Bone fractures associated with luteinizing hormone-releasing hormone agonists used in the treatment of prostate carcinoma
  Cancer, 1997
• Severe Osteoporosis in Men
  Annals of Internal Medicine, 1995
• Bone mineral density in patients with prostatic cancer treated with orchidectomy and with estrogens
  Calcified Tissue International, 1995
• Gonadotrophin-releasing Hormone Agonists Induce Osteoporosis
  Rheumatology, 1994
• Decreased bone density in elderly men treated with the gonadotropin- releasing hormone agonist decapeptyl (D-Trp6-GnRH)
  Journal of Clinical Endocrinology & Metabolism, 1993
• Testosterone Deficiency As a Risk Factor for Hip Fractures in Men: A Case-Control Study
  The Lancet Healthy Longevity, 1992
• Risk factors for spinal osteoporosis in men
  The American Journal of Medicine, 1983